U.S. Transportation Department To Examine Southwest Airlines' Mass Flight Cancellations

The U.S. Department of Transportation said that it would examine Southwest Airlines Co.'s (LUV) mass flight cancellations and delays.

"USDOT is concerned by Southwest's unacceptable rate of cancellations and delays & reports of lack of prompt customer service. The Department will examine whether cancellations were controllable and if Southwest is complying with its customer service plan," the Transportation Department tweeted late on Monday.

The strong winter storm resulted in the cancellation of thousands of flights during the long Christmas weekend. The total number of cancellations as of Monday was 2767.

Out of the total delays of 5319 flights, 641 flights were delayed within and into or out of the United States.

According to the flight tracking website FlightAware, Southwest Airlines alone canceled 725 flights and 103 flights were delayed. On Friday cancellations by Southwest were 1238 flights.

The deadly winter storm reportedly affected more than 200 million people and at least 12 people were dead.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Elon Musk's brain implant firm Neuralink said it has received approval from the U.S. Food and Drug Administration to conduct first-in-human clinical trials. In a tweet, Neuralink said, "We are excited to share that we have received the FDA's approval to launch our first-in-human clinical study! T.W. Garner Food Co. is recalling 50,688 bottles of 12 oz. Texas Pete Buffalo Wing Sauce citing undeclared soy, the U.S. Food and Drug Administration said. The agency noted that some of the bottles may contain Texas Pete Extra Mild Wing Sauce which contains soy. The recall involves Texas Pete Buffalo Wing Sauce with best used by 120623T 065239 UPC 0 75500 10011 6. The U.S. Food and Drug Administration approved Pfizer Inc's COVID-19 oral antiviral pill Paxlovid for the treatment of mild-to-moderate COVID-19 in adults. Paxlovid is the first oral treatment, and the fourth drug, approved by the agency to treat COVID-19 in adults. Paxlovid (nirmatrelvir tablets and ritonavir tablets, co-packaged for oral use) has been approved to treat adults who are at high...
Follow RTT